Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Willis Towers Watson Public Limited Company - Ordinary Shares (NQ:WTW)

335.47 +2.91 (+0.88%)
Streaming Delayed Price Updated: 12:06 PM EST, Dec 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Willis Towers Watson Public Limited Company - Ordinary Shares

< Previous 1 2 3 4 5 6 Next >
News headline image
Willis Towers Watson To See Short-Term Success Amid Defined Benefit Plan Shifts - Analyst Upgrades Stock ↗
Analyst Zaremski upgraded Willis Towers Watson to Market Perform, predicting continued growth and strong performance in broking and DB segments. 
Via Benzinga
News headline image
Fear & Greed Index Remains In 'Greed' Zone Following Earnings Reports; Dow Jumps Over 100 Points ↗
The CNN Money Fear and Greed index showed a slight improvement in the overall market sentiment, while the index remained in the "Greed" zone on Tuesday. U.S. stocks closed higher on Tuesday, as... 
Via Benzinga
Topics Stocks
News headline image
Willis Towers Stock Pops On Strongest Earnings Growth In A Year ↗
Willis Towers stock holds the No. 3 rank among its peers in the 15-stock Insurance-Brokers industry group. It got a rating upgrade Wednesday. 
Via Investor's Business Daily
News headline image
Nasdaq Down 50 Points; Willis Towers Watson Posts Upbeat Profit ↗
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite falling around 50 points on Tuesday. The Dow traded up 0.11% to 38,422.51 while the NASDAQ fell 0.32% to 15,547.61. The S&P... 
Via Benzinga
Topics Stocks
News headline image
Insurance Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
Earnings Scheduled For February 6, 2024 ↗
Companies Reporting Before The Bell • BP (NYSE:BP) is projected to report quarterly earnings at $1.05 per share on revenue of $53.50 billion. 
Via Benzinga
News headline image
Where Willis Towers Watson Stands With Analysts ↗
 
Via Benzinga
News headline image
Analyst Ratings for Willis Towers Watson ↗
 
Via Benzinga
News headline image
Chewy To Rally Over 50%? Here Are 10 Top Analyst Forecasts For Thursday ↗
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
News headline image
Some Surprise Names Led The S&P 500 In October ↗
The best and worst stock performers in the S&P 500 for October include some surprising names. 
Via Investor's Business Daily
Topics Stocks
News headline image
Bears Roam Wall Street As Middle East Conflict, Earnings Outlook Raise Concerns Despite Strong Q3 US Economic Growth: This Week In Markets ↗
It has been another week of volatility in the stock market, characterized by mounting fears of a wider Middle East conflict and a more cautious fourth-quarter earnings outlook announced by U.S.... 
Via Benzinga
News headline image
Where Willis Towers Watson Stands With Analysts ↗
 
Via Benzinga
News headline image
What 7 Analyst Ratings Have To Say About Willis Towers Watson ↗
 
Via Benzinga
News headline image
These Analysts Increase Their Forecasts On Willis Towers Watson After Upbeat Earnings ↗
Willis Towers Watson Public Limited Company (NASDAQ: WTW) reported better-than-expected third-quarter results on Thursday. 
Via Benzinga
News headline image
How To Earn $500 A Month From Willis Towers Watson Stock Following Upbeat Earnings ↗
Willis Towers Watson Public Limited Company (NASDAQ: WTW) reported better-than-expected third-quarter results on Thursday. 
Via Benzinga
News headline image
Insurance Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
Insurance Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
GoDaddy To Rally Around 44%? Here Are 10 Other Analyst Forecasts For Wednesday ↗
Needham cut the price target for Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) from $60 to $53. Needham analyst Gil Blum maintained a Buy rating. Rocket Pharmaceuticals shares rose 24.3% to $19.00 in... 
Via Benzinga
News headline image
The Latest Analyst Ratings for Willis Towers Watson ↗
 
Via Benzinga
News headline image
How Is The Market Feeling About Willis Towers Watson? ↗
 
Via Benzinga
News headline image
Why Harley-Davidson Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
Gainers 
Via Benzinga
News headline image
Future Challenges For Willis Towers Watson: Analyst Cautions On Downward EPS Revisions Amid Hiring Headwinds ↗
BMO Capital Market analyst Michael Zaremski downgraded Willis Towers Watson PLC (NASDAQ: WTW) to Underperform from Market Perform at a decreased  
Via Benzinga
News headline image
IBM, ServiceNow, Lennox, Morningstar And Other Big Stocks Moving Higher On Thursday ↗
U.S. stocks traded lower, with the Nasdaq Composite falling more than 90 points on Thursday. Here are some big stocks bucking the trend and recording gains in today’s session. 
Via Benzinga
Topics Stocks
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2023 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For October 26, 2023 ↗
Companies Reporting Before The Bell • TotalEnergies (NYSE:TTE) is likely to report quarterly earnings at $2.57 per share on revenue of $49.83 billion. 
Via Benzinga
News headline image
Insurance Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
Goldman Sachs Reveals Long-Term AI Portfolio: Here Are The 50 Stocks To Monitor ↗
 
Via Benzinga
Topics Artificial Intelligence
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For July 28, 2023 ↗
 
Via Benzinga
News headline image
Why Willis Towers Watson Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
Gainers Femasys Inc. (NASDAQ: FEMY) gained 54% to $0.55. Femasys reported a notice of allowance for new U.S. patent application covering use of FemBloc for female permanent birth control. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For July 27, 2023 ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.